ASLAN Pharmaceuticals
ASLN
#10190
Rank
NZ$3 M
Marketcap
$1.06
Share price
-14.27%
Change (1 day)
-93.09%
Change (1 year)

Revenue for ASLAN Pharmaceuticals (ASLN)

Revenue in 2024 (TTM): NZ$19.77 Million

According to ASLAN Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is NZ$21.21 Million. In 2023 the company made a revenue of NZ$18.97 Million an increase over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ASLAN Pharmaceuticals from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$19.77 M4.24%
2023 NZ$18.97 M
2022 N/A
2021 N/A
2020 N/A-100%
2019 NZ$4.45 M